Time to alignment · People receiving orthodontic treatment with fixed appliances (upper and/or lower full arch)
The review found no eligible studies for this question.
1 finding from 1 review
Pain · People receiving orthodontic treatment with fixed appliances (upper and/or lower full arch)
The review found no eligible studies for this question.
1 finding from 1 review
Pain: not reported
0 studies
No studies found
Time to next/working arch wire · People receiving orthodontic treatment with fixed appliances (upper and/or lower full arch)
The review found no eligible studies for this question.
1 finding from 1 review
Root resorption · People receiving orthodontic treatment with fixed appliances (upper and/or lower full arch)
The review found no eligible studies for this question.
1 finding from 1 review
Restoration failure · Children (2-9 years) with caries in posterior primary teeth
Single-surface ART restorations had a low reported mean annual failure rate (about 5%; ungraded).
1 finding from 1 review
Restoration survival · Children with decayed primary molar teeth
Single-surface ART/HVGIC restorations had high reported survival (86% at 3 years), significantly higher than multi-surface restorations (ungraded).
1 finding from 1 review
Survival rate (%) 86
9 studies
GRADE not reported
Participants with severe haemolysis · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.4 to 0.5 mg/kg showed no clear difference in participants with severe haemolysis compared with no primaquine, with artemisinin partner, (low certainty).
1 finding from 1 review
Participants with gametocytes at day 4‐5, by microscopy · adults and children with malaria being treated with non‐artemisinin treatment
Single dose primaquine at 0.4 to 0.5 mg/kg showed no clear difference in participants with gametocytes at day 4‐5, by microscopy compared with no primaquine, with non‐artemisinin partner, (moderate certainty).
1 finding from 1 review
Participants with gametocytes at day 8, by microscopy · adults and children with malaria being treated with non‐artemisinin treatment
Single dose primaquine at 0.4 to 0.5 mg/kg probably leads to lower participants with gametocytes at day 8, by microscopy compared with no primaquine, with non‐artemisinin partner, (moderate certainty).
1 finding from 1 review
Participants infectious at day 8 · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.4 to 0.5 mg/kg may leads to lower participants infectious at day 3‐4 compared with no primaquine, with artemisinin partner, (low certainty).
2 findings from 1 review
Participants with gametocytes at day 3‐4, by PCR · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.4 to 0.5 mg/kg showed no clear difference in participants with gametocytes at day 3‐4, by PCR compared with no primaquine, with artemisinin partner, (moderate certainty).
1 finding from 1 review
Participants with gametocytes at day 8, by PCR · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.4 to 0.5 mg/kg leads to lower participants with gametocytes at day 8, by PCR compared with no primaquine, with artemisinin partner, (high certainty).
1 finding from 1 review
Treatment failure (annual failure rate) by cavity class · Children with carious primary teeth restored in Class-I versus Class-II cavities, no pulp therapy
Class-II restorations failed more than Class-I (annual failure 5-28.9% vs 1.2-14.7% in ART studies); low quality of evidence (ungraded).
1 finding from 1 review
Participants infectious at day 8 · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.2 to 0.25 mg/kg may leads to lower participants infectious at day 3‐4 compared with no primaquine, with artemisinin partner, (low certainty).
2 findings from 1 review
Participants with gametocytes at day 3‐4, by PCR · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.2 to 0.25 mg/kg showed no clear difference in participants with gametocytes at day 3 to 4 by PCR compared with no primaquine, with artemisinin partner, (moderate certainty).
1 finding from 1 review
Participants with gametocytes at day 8, by PCR · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.2 to 0.25 mg/kg leads to lower participants with gametocytes at day 8 by PCR compared with no primaquine, with artemisinin partner, (high certainty).
1 finding from 1 review
Participants with severe haemolysis · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.2 to 0.25 mg/kg showed no clear difference in participants with severe haemolysis compared with no primaquine, with artemisinin partner, (moderate certainty).
1 finding from 1 review
First dentine caries incidence rate per person-year at risk (D3) · Caries-free children and adolescents with permanent dentition
Sánchez-Pérez et al. 2010 reported an incidence rate of 0.07 per person-year at risk.
16 findings from 1 review
Show 13 more findings
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.14 [0.13, 0.15]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.14 [0.12, 0.16]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.16 [0.15, 0.17]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.12 [0.12, 0.12]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.14 [0.13, 0.16]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.20 [0.18, 0.23]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.06 [0.06, 0.06]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.11 [0.10, 0.12]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.21 [0.18, 0.25]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.12 [0.11, 0.13]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.09 [0.09, 0.10]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.06 [0.06, 0.07]
1 study
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesFollow-up of at least 3 years · Western or comparable populations
Incidence rate per person-year at risk 0.09 [0.09, 0.09]
1 study
GRADE not reported
Cumulative live birth · transfer following in vitro fertilisation or intracytoplasmic sperm injection
Repeated single embryo transfer (mixed policies) showed no clear difference in cumulative live birth compared with multiple embryo transfer (low certainty).
1 finding from 1 review
Multiple pregnancy · transfer following in vitro fertilisation or intracytoplasmic sperm injection
Repeated single embryo transfer (mixed policies) probably leads to lower multiple pregnancy compared with multiple embryo transfer (moderate certainty).
1 finding from 1 review